2022 COLOGUARD CLASSIC FIELD NEARLY SET
Sponsor Exemptions Announced
The star-studded field (full field below) now features 10 of the top 10 from the 2020-21 Charles Schwab Cup points race, including 2020 Cologuard Classic tournament champion Bernhard Langer; University of Arizona alum and reigning PGA TOUR Champions Rookie of the Year Jim Furyk; Miguel Angel Jimenez; World Golf Hall of Fame member Ernie Els; Cologuard ambassador Jerry Kelly; Darren Clarke; Retief Goosen; defending tournament champion Kevin Sutherland; and 2021 tournament runner-up Mike Weir. In addition, David Duval will be making his PGA TOUR Champions Tucson debut. While playing on the PGA TOUR, Duval had 13 career victories, including the 1998 Tucson Chrysler Classic, also played at Tucson National.
Members of the 2022 Cologuard Classic field have combined to win 328 PGA TOUR tournaments, 226 PGA TOUR Champions events and 41 major victories (PGA TOUR and PGA TOUR Champions). There are six past Cologuard Classic champions in the field, including: Kevin Sutherland (2021), Bernhard Langer (2020), Mark O’Meara (2019), Tom Lehman (2017), Woody Austin (2016), and Marco Dawson (2015).
John Daly will be playing in his fifth career Cologuard Classic and his third on a sponsor exemption (2019, 2020). His best finish in Tucson is a T9 at the 2020 Cologuard Classic. Andrade will be playing in his eighth consecutive Cologuard Classic, with his best finish coming in 2017 when he tied for fourth. Tiziani will be making his Cologuard Classic playing debut. The 51-year-old from Madison, Wisconsin played in two PGA TOUR Champions events during the 2021 season, finishing T11 at the Sanford International. He is the brother-in-law and agent of Steve Stricker, and regularly caddies for the 2018 Cologuard Classic champion. Phoenix-resident Ken Tanigawa also received a sponsor exemption. Winner of the 2019 KitchenAid Senior PGA Championship, Tanigawa will be playing in his fifth Cologuard Classic. Harrison Frazar is a PGA TOUR
Champions rookie after turning 50 in July 2021. In four events played last season, the Dallas, Texas-native had two top 25 finishes.
Cologuard Classic tickets and hospitality packages are on sale on the tournament’s website, www.CologuardClassic.com for Friday, Saturday and Sunday (Feb. 25 -27). Admission to the second round of the tournament on Saturday, Feb. 26th, includes admission to the golf tournament; the Celebrity Challenge featuring Eric Dickerson, Larry Fitzgerald, Jake Owen and Annika Sorenstam; and the evening Cologuard Classic Military Tribute Concert sponsored by NOVA Home Loans & DM50 featuring country music artists Jake Owen and Diamond Rio. Saturday is also “Dress in Blue Day” at the tournament, in which fans and golfers are encouraged to wear blue in support of colorectal cancer awareness.
For more information on the 2022 Cologuard Classic, visit www.CologuardClassic.com or call 520-571-0400.
About The Tucson Conquistadores
The Tucson Conquistadores are the tournament management team that oversees the operations and the sales arm of the PGA TOUR Champions’ Cologuard Classic. Since their inception in 1962, the Conquistadores have contributed more than $36.5 million to local and national charities. The Conquistadores are comprised of up to 57 active business and professional members and a total membership of 224 who represent a cross-section of the Tucson community. In addition to their involvement with professional golf, the group has established the Tucson Conquistadores Foundation. Key beneficiaries of the Conquistadores' fundraising efforts include southern Arizona youth athletic programs, First Tee Tucson and colon cancer advocacy organizations. Follow the Tucson Conquistadores online at www.tucsonconquistadores.com and www.Facebook.com/TucsonConquistadores.
About PGA TOUR Champions
PGA TOUR Champions is a membership organization of professional golfers age 50 and older, including 34 members of the World Golf Hall of Fame. The Tour’s mission is to provide financial opportunities for its players, entertain and inspire its fans, deliver substantial value to its partners, create outlets for volunteers to give back and generate significant charitable and economic impact in tournament communities. Follow PGA TOUR Champions online at PGATOUR.com, at facebook.com/PGATOURChampions, on Twitter @ChampionsTour and on Instagram @pgatourchampions.
All events are televised in the United States, with most receiving complete coverage on Golf Channel, the exclusive cable-television partner of PGA TOUR Champions. Tournament programming is available via 25+ TV linear partners in 145+ countries and territories, with 25 channels carrying long-form and/or highlights coverage, and 200+ hours of live coverage distributed in 135+ countries and territories. Programming is also available via the OTT platform GOLFTV powered by PGA TOUR in every market outside of the United States, excluding China and Korea, with live coverage distributed in 130+ countries and territories.
Cologuard was approved by the FDA in August 2014, and results from Exact Sciences' prospective 90-site, point-in-time, 10,000-patient pivotal trial in adults 50 years of age or older were published in the New England Journal of Medicine in March 2014. Cologuard is included in the American Cancer Society's (2018) colorectal cancer screening guidelines and the recommendations of the U.S. Preventive Services Task Force (2016, 2021) and National Comprehensive Cancer Network (2016). Cologuard is indicated to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA
markers and blood in the stool. Do not use Cologuard if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or have a personal or family history of colorectal cancer. Cologuard is not a replacement for colonoscopy in high-risk patients. Cologuard performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older. Cologuard performance in repeat testing has not been evaluated.
The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for diagnostic colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. False positives and false negative results can occur. In a clinical study, 13% of people without cancer received a positive result (false positive) and 8% of people with cancer received a negative result (false negative). Rx only.
Medicare and most major insurers cover Cologuard. For more information about Cologuard, visit www.cologuard.com.
Tournament Media Contact:
Jimenez, Miguel Angel
Olazabal, Jose Maria
Short, Jr., Wes
*indicates sponsor exemption